Dear Readers,
dear Business Associates,
Biopharmaceuticals are gaining ground worldwide, opening up new opportunities in medical science and their market share is growing steadily. Advanced Therapy Medicinal Products (ATMPs) offer hope for the treatment of diseases such as cancer, Parkinson’s, diabetes or Alzheimer’s, for which there have been insufficient or no therapies until now.
However, these gene and cell therapeutics as well as biotechnologically processed tissue products also pose new challenges for pharmaceutical and machine manufacturers. Sterile production throughout and aseptic filling into bags, syringes or vials are crucial.
Harro Höfliger’s experts have already developed trend-setting solutions for numerous projects. Yet fewer standards than ever can be established. This is why we work closely with our customers to implement individual, holistic solutions.
In order to pick up the pace in this area, we are working relentlessly to develop preassembled modules for flexibly configurable machine platforms. We devote all of our expertise to the development of the necessary aseptic production processes, as you can read in the article “Aseptic pharmaceuticals: Open to new approaches”.
Biopharmaceuticals are the future. The exciting challenges go hand in hand with our philosophy “The product determines the process” and spur our creativity and innovative spirit.
“ALL YOU NEED” – our promise now and in the future.
Your
Thomas Weller,
CEO at Harro Höfliger
Download this article as PDF file
Photo: Janine Kyofsky